Treatment of Alzheimer's disease : Rationale and strategiesGRUNDMAN, Michael; THAL, Leon J.Neurologic clinics. 2000, Vol 18, Num 4, pp v-vi, issn 0733-8619, 23 p.Article

Potential Impact of Amyloid Imaging on Diagnosis and Intended Management in Patients With Progressive Cognitive DeclineGRUNDMAN, Michael; PONTECORVO, Michael J; AGBULOS, Abigail et al.Alzheimer disease and associated disorders. 2013, Vol 27, Num 1, pp 4-15, issn 0893-0341, 12 p.Article

Volumetric MRI and cognitive measures in Alzheimer disease : Comparison of markers of progressionRIDHA, Basil H; ANDERSON, Valerie M; FOX, Nick C et al.Journal of neurology. 2008, Vol 255, Num 4, pp 567-574, issn 0340-5354, 8 p.Article

Vitamin E and donepezil for the treatment of mild cognitive impairmentPETERSEN, Ronald C; THOMAS, Ronald G; PFEIFFER, Eric et al.The New England journal of medicine. 2005, Vol 352, Num 23, pp 2379-2388, issn 0028-4793, 10 p.Article

Estrogen levels do not correlate with improvement in cognitionTHAL, Leon J; THOMAS, Ronald G; MULNARD, Ruth et al.Archives of neurology (Chicago). 2003, Vol 60, Num 2, pp 209-212, issn 0003-9942, 4 p.Article

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's DiseaseSALLOWAY, Stephen; SPERLING, Reisa; REICHERT, Marcel et al.The New England journal of medicine. 2014, Vol 370, Num 4, pp 322-333, issn 0028-4793, 12 p.Article

Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer DiseaseBLENNOW, Kaj; ZETTERBERG, Henrik; RINNE, Juha O et al.Archives of neurology (Chicago). 2012, Vol 69, Num 8, pp 1002-1010, issn 0003-9942, 9 p.Article

Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementiaDECARLI, Charles; FRISONI, Giovanni B; CLARK, Christopher M et al.Archives of neurology (Chicago). 2007, Vol 64, Num 1, pp 108-115, issn 0003-9942, 8 p.Article

A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's DiseaseSINGER, Clifford; TRACTENBERG, Rochelle E; KAYE, Jeffrey et al.Sleep (New York, NY). 2003, Vol 26, Num 7, pp 893-901, issn 0161-8105, 9 p.Article

Prevalence of symptoms on the CERAD behavior rating scale for Dementia in normal elderly subjects and Alzheimer's disease patientsTRACTENBERG, Rochelle E; PATTERSON, Marian; WEINER, Myron F et al.The Journal of neuropsychiatry and clinical neurosciences. 2000, Vol 12, Num 4, pp 472-479, issn 0895-0172Article

Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer diseasePRICE, Joseph L; MCKEEL, Daniel W; SMITH, Charles D et al.Neurobiology of aging. 2009, Vol 30, Num 7, pp 1026-1036, issn 0197-4580, 11 p.Article

A neuropsychological test battery for use in Alzheimer disease clinical trialsHARRISON, John; MINASSIAN, Sonia L; JENKINS, Lisa et al.Archives of neurology (Chicago). 2007, Vol 64, Num 9, pp 1323-1329, issn 0003-9942, 7 p.Article

Sex, apolipoprotein E ε4 status, and hippocampal volume in mild cognitive impairmentFLEISHER, Adam; GRUNDMAN, Michael; DECARLI, Charles et al.Archives of neurology (Chicago). 2005, Vol 62, Num 6, pp 953-957, issn 0003-9942, 5 p.Article

Laboratory investigations and treatment in frontotemporal dementiaPASQUIER, Florence; FUKUI, Toshiya; SARAZIN, Marie et al.Annals of neurology. 2003, Vol 54, pp S32-S35, issn 0364-5134, SUP5Conference Paper

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: A randomized controlled trialAISEN, Paul S; SCHAFER, Kimberly A; GRUNDMAN, Michael et al.JAMA, the journal of the American Medical Association. 2003, Vol 289, Num 21, pp 2819-2826, issn 0098-7484, 8 p.Article

Cognition in MCI and Alzheimer's Disease: Baseline Data from a Longitudinal Study of the NTBHARRISON, John; RENTZ, Dorene M; McLAUGHLIN, Trent et al.Neuropsychology, development, and cognition. Section D, The clinical neuropsychologist. 2014, Vol 28, Num 2, pp 252-268, issn 1385-4046, 17 p.Article

Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter studyMURALI DORAISWAMY, P; SPERLING, Reisa A; CARPENTER, Alan et al.Neurology. 2012, Vol 79, Num 16, pp 1636-1644, issn 0028-3878, 9 p.Article

A Single Ascending Dose Study of Bapineuzumab in Patients With Alzheimer DiseaseBLACK, Ronald S; SPERLING, Reisa A; SAFIRSTEIN, Beth et al.Alzheimer disease and associated disorders. 2010, Vol 24, Num 2, pp 198-203, issn 0893-0341, 6 p.Article

Older Americans' Risk-benefit Preferences for Modifying the Course of Alzheimer DiseaseHAUBER, A. Brett; JOHNSON, F. Reed; FILLIT, Howard et al.Alzheimer disease and associated disorders. 2009, Vol 23, Num 1, pp 23-32, issn 0893-0341, 10 p.Article

Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trialsGRUNDMAN, Michael; PETERSEN, Ronald C; KAYE, Jeffrey et al.Archives of neurology (Chicago). 2004, Vol 61, Num 1, pp 59-66, issn 0003-9942, 8 p.Article